Literature DB >> 23392090

Thyroid hormone transporters and resistance.

Theo J Visser1.   

Abstract

Cellular entry is an important step preceding intracellular metabolism and action of thyroid hormone (TH). Transport of TH across the plasma membrane does not take place by simple diffusion but requires transporter proteins. One of the most effective and specific TH transporters identified to date is monocarboxylate transporter 8 (MCT8), the gene of which is located on the X chromosome. Although MCT8 is expressed in many tissues, its function appears to be most critical in the brain. Hemizygous MCT8 mutations in males cause severe psychomotor retardation, known as the Allan-Herndon-Dudley syndrome (AHDS), and abnormal serum TH levels. AHDS thus represents a type of TH resistance caused by a defect in cellular TH transport.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23392090     DOI: 10.1159/000343695

Source DB:  PubMed          Journal:  Endocr Dev        ISSN: 1421-7082


  9 in total

1.  Parallel regulation of thyroid hormone transporters OATP1c1 and MCT8 during and after endotoxemia at the blood-brain barrier of male rodents.

Authors:  Gábor Wittmann; Judit Szabon; Petra Mohácsik; Shira S Nouriel; Balázs Gereben; Csaba Fekete; Ronald M Lechan
Journal:  Endocrinology       Date:  2015-01-16       Impact factor: 4.736

Review 2.  Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.

Authors:  Stephen J Fairweather; Nishank Shah; Stefan Brӧer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Thyroid hormone regulation of neural stem cell fate: From development to ageing.

Authors:  Jean-David Gothié; Pieter Vancamp; Barbara Demeneix; Sylvie Remaud
Journal:  Acta Physiol (Oxf)       Date:  2019-06-17       Impact factor: 7.523

4.  Plasma proteome and metabolome characterization of an experimental human thyrotoxicosis model.

Authors:  Maik Pietzner; Beatrice Engelmann; Tim Kacprowski; Janine Golchert; Anna-Luise Dirk; Elke Hammer; K Alexander Iwen; Matthias Nauck; Henri Wallaschofski; Dagmar Führer; Thomas F Münte; Nele Friedrich; Uwe Völker; Georg Homuth; Georg Brabant
Journal:  BMC Med       Date:  2017-01-09       Impact factor: 8.775

5.  A clinician's guide to understanding resistance to thyroid hormone due to receptor mutations in the TRα and TRβ isoforms.

Authors:  Brijesh K Singh; Paul M Yen
Journal:  Clin Diabetes Endocrinol       Date:  2017-09-15

Review 6.  Thyroid Diseases and Breast Cancer.

Authors:  Enke Baldini; Augusto Lauro; Domenico Tripodi; Daniele Pironi; Maria Ida Amabile; Iulia Catalina Ferent; Eleonora Lori; Federica Gagliardi; Maria Irene Bellini; Flavio Forte; Patrizia Pacini; Vito Cantisani; Vito D'Andrea; Salvatore Sorrenti; Salvatore Ulisse
Journal:  J Pers Med       Date:  2022-01-25

Review 7.  Is Melanoma Progression Affected by Thyroid Diseases?

Authors:  Salvatore Ulisse; Enke Baldini; Daniele Pironi; Federica Gagliardi; Domenico Tripodi; Augusto Lauro; Sabino Carbotta; Danilo Tarroni; Matteo D'Armiento; Aldo Morrone; Flavio Forte; Flaminia Frattaroli; Severino Persechino; Teresa Odorisio; Vito D'Andrea; Eleonora Lori; Salvatore Sorrenti
Journal:  Int J Mol Sci       Date:  2022-09-02       Impact factor: 6.208

Review 8.  Genetic disorders of thyroid metabolism and brain development.

Authors:  Manju A Kurian; Heinz Jungbluth
Journal:  Dev Med Child Neurol       Date:  2014-03-26       Impact factor: 5.449

9.  Overcoming Monocarboxylate Transporter 8 (MCT8)-Deficiency to Promote Human Oligodendrocyte Differentiation and Myelination.

Authors:  Jae Young Lee; Min Joung Kim; Devy Deliyanti; Michael F Azari; Fernando Rossello; Adam Costin; Georg Ramm; Edouard G Stanley; Andrew G Elefanty; Jennifer L Wilkinson-Berka; Steven Petratos
Journal:  EBioMedicine       Date:  2017-10-19       Impact factor: 8.143

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.